Insights

Reset

ADVI insights

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

AI in the Patient Care Paradigm: Examining Regulatory Challenges to Clinical Adoption  

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

FDA Proposes Down-Classification of Oncology Companion Diagnostics: A Q&A on Precision Medicine

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

2026 Life Sciences Forecast: AI, Next-Gen Cell & Gene Therapy, and Policy Disruption

Insights,

| Ashis Kumar Das, PhD, MD, MPH - Director

What HEOR Information Does CMS Need for Drug Price Negotiations Under the IRA?
View All

Case Studies

Case Study: Rare Disease State Policy Engagement

Case Study: Medicare Part D Liability Model 

Case Study: Strengthening Positioning for IRA Drug Price Negotiation

Case Study: Medicare Utilization and Cost Trends for CAR-T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma
View All

Events

Events ADVI Health Attending ISPOR Europe 2025
Events ADVI Health Attending AMCP Nexus 2025
Events ADVI Health Experts Attending AVBCC 2025
Events ADVI Health Attending Meeting on the Mesa 2025
Events ADVI Health Attending Cure SMA Annual Conference
ADVI Health at Access Forum Events ADVI Health is Attending Access Forum US
View All

News

In The News ADVI Health’s Ashis Das Featured in First Report Managed Care
In The News ADVI Health Co-Authored Abstracted Featured at ASH Annual 2025
In The News ADVI Health’s Ashis Das Featured in Health Economics
In The News ADVI’s Alicia Silver Discusses the Cell and Gene Therapy Landscape with the Empowered Patient Podcast
In The News ADVI Health’s Lindsay Bealor Greenleaf Featured in Pink Sheet
In The News ADVI Health Experts Featured in STAT: Navigating Recent and Upcoming CMS Policy Shifts
View All

Videos

A Holiday Message from ADVI Health

ADVI Expert Shares Insight on Recent Policy Developments: OBBA, IRA Negotiation, and HRSA

ADVI Expert John Coster Shares Insights from ACCESS Forum 2025: Medicare Drug Pricing

ADVI Experts Lindsay Greenleaf and Alicia Silver Share Insight After ACCESS Forum 2025 Panels
View All